421 studies found for:    United States, Vermont | University of Vermont
Show Display Options
Rank Status Study
21 Recruiting Isotretinoin With or Without Monoclonal Antibody Ch14.18, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma
Conditions: Disseminated Neuroblastoma;   Localized Resectable Neuroblastoma;   Localized Unresectable Neuroblastoma;   Regional Neuroblastoma;   Stage 4S Neuroblastoma
Interventions: Drug: isotretinoin;   Biological: sargramostim;   Biological: dinutuximab;   Biological: aldesleukin;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment;   Other: pharmacological study
22 Unknown  Campylobacter Jejuni Challenge Model Development: Assessment of Homologous Protection
Condition: Campylobacter Infections
Intervention: Biological: Campylobacter jejuni strain CG8421
23 Active, not recruiting Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Conditions: Adult Rhabdomyosarcoma;   Alveolar Childhood Rhabdomyosarcoma;   Embryonal Childhood Rhabdomyosarcoma;   Metastatic Childhood Soft Tissue Sarcoma;   Previously Untreated Childhood Rhabdomyosarcoma;   Stage IV Adult Soft Tissue Sarcoma
Interventions: Biological: cixutumumab;   Drug: doxorubicin hydrochloride;   Drug: irinotecan hydrochloride;   Drug: liposomal vincristine sulfate;   Drug: ifosfamide;   Drug: etoposide;   Drug: cyclophosphamide;   Biological: dactinomycin;   Drug: temozolomide;   Other: laboratory biomarker analysis
24 Active, not recruiting Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Recurrent Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Drug: sunitinib malate;   Drug: pemetrexed disodium
25 Completed Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Conditions: Heart Failure;   Elevated Serum Uric Acid
Interventions: Drug: allopurinol;   Drug: sugar pill
26 Completed Attempts to Stop/Reduce Marijuana Among Dependent Users
Conditions: Marijuana Abuse;   Marijuana Dependence
Intervention:
27 Active, not recruiting Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
Conditions: Adult Rhabdomyosarcoma;   Alveolar Childhood Rhabdomyosarcoma;   Mixed Childhood Rhabdomyosarcoma;   Pleomorphic Childhood Rhabdomyosarcoma;   Previously Treated Childhood Rhabdomyosarcoma;   Recurrent Adult Soft Tissue Sarcoma;   Recurrent Childhood Rhabdomyosarcoma
Interventions: Drug: vinorelbine tartrate;   Drug: cyclophosphamide;   Biological: bevacizumab;   Drug: temsirolimus;   Other: laboratory biomarker analysis
28 Completed Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
Conditions: Childhood Hepatoblastoma;   Previously Treated Childhood Rhabdomyosarcoma;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Acute Myeloid Leukemia;   Recurrent Childhood Malignant Germ Cell Tumor;   Recurrent Childhood Rhabdomyosarcoma;   Recurrent Childhood Soft Tissue Sarcoma;   Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Recurrent Neuroblastoma;   Recurrent Osteosarcoma;   Recurrent Wilms Tumor and Other Childhood Kidney Tumors
Interventions: Drug: alisertib;   Other: pharmacological study;   Other: laboratory biomarker analysis
29 Active, not recruiting Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
Conditions: Childhood Acute Basophilic Leukemia;   Childhood Acute Eosinophilic Leukemia;   Childhood Acute Erythroleukemia (M6);   Childhood Acute Megakaryocytic Leukemia (M7);   Childhood Acute Minimally Differentiated Myeloid Leukemia (M0);   Childhood Acute Monoblastic Leukemia (M5a);   Childhood Acute Monocytic Leukemia (M5b);   Childhood Acute Myeloblastic Leukemia With Maturation (M2);   Childhood Acute Myeloblastic Leukemia Without Maturation (M1);   Childhood Acute Myelomonocytic Leukemia (M4);   Childhood Myelodysplastic Syndromes;   de Novo Myelodysplastic Syndromes;   Secondary Acute Myeloid Leukemia;   Secondary Myelodysplastic Syndromes;   Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
Interventions: Drug: asparaginase;   Drug: daunorubicin hydrochloride;   Drug: cytarabine;   Drug: thioguanine;   Drug: etoposide;   Other: laboratory biomarker analysis
30 Completed Acupuncture Needling on Connective Tissue by Ultrasound
Condition: Healthy
Intervention:
31 Active, not recruiting
Has Results
Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
Conditions: Mucosal Melanoma;   Recurrent Melanoma;   Stage IIIB Melanoma;   Stage IIIC Melanoma;   Stage IV Melanoma
Interventions: Drug: paclitaxel;   Drug: carboplatin;   Drug: sorafenib tosylate;   Other: placebo;   Other: pharmacological study;   Other: laboratory biomarker analysis
32 Completed RCT Comparing Methadone and Buprenorphine in Pregnant Women
Conditions: Opioid Related Disorders;   Pregnancy;   Opioid Dependence
Interventions: Drug: Methadone;   Drug: Buprenorphine
33 Active, not recruiting Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
Conditions: Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma;   Stage III Childhood Hodgkin Lymphoma;   Stage IV Childhood Hodgkin Lymphoma
Interventions: Biological: bleomycin sulfate;   Drug: doxorubicin hydrochloride;   Drug: liposomal vincristine sulfate;   Drug: vinorelbine tartrate;   Drug: cyclophosphamide;   Drug: etoposide phosphate;   Drug: prednisone;   Biological: filgrastim;   Drug: ifosfamide
34 Recruiting Increasing Cardiac Rehabilitation Participation Among Medicaid Enrollees
Condition: Coronary Artery Disease
Intervention: Behavioral: Financial incentives
35 Unknown  Bone Turnover in Type 2 Diabetes Patients
Condition: Type 2 Diabetes
Interventions: Drug: Sitagliptin;   Drug: Placebo
36 Terminated Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Condition: Ocular Myasthenia Gravis
Interventions: Drug: Prednisone;   Drug: Placebo
37 Recruiting Not Quite Ready to Quit
Condition: Smoking Cessation
Interventions: Behavioral: Usual care;   Behavioral: Reduction;   Behavioral: 5Rs
38 Unknown  The Effect of Estrogen and Progesterone Levels on Knee and Ankle Joint Laxity
Condition: Healthy
Intervention:
39 Completed Minocycline to Treat Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: minocycline
40 Completed
Has Results
Long-term Effect of Lanthanum Carbonate on Bone
Condition: Hyperphosphatemia
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years